ABVC: מכפיל P/S ABVC BioPharma Inc.

P/S volatility on GURU.Markets reflects the market risks facing ABVC BioPharma in the presence of major pharma behemoths, with the current parameter equal to 43.70. ABVC BioPharma develops plant-based treatments for ADHD and depression, scaling sales through global licensing. The asset's value growth is based on FDA approvals, patent expansion, and payments from Asian partners.

Professional managers utilize fundamental filters to separate overvalued assets from those with growth potential. The P/S ratio compares market capitalization to annual revenue, determining the cost of one ruble of sales within the share price. For ABVC BioPharma, which depends on investments and research outcomes, this metric reflects market expectations for future products. Analyzing the P/S ratio chart helps balance risk and potential return.